Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Breast Lesion Localization Methods Market Outlook

The global breast lesion localization methods market size was valued at USD 292.08 million in 2023, driven by the emphasis on preventing the increasing cases of breast cancer across the globe. The market is expected to grow at a CAGR of 4.8% during the forecast period of 2024-2032, with the values likely to rise from USD 306.10 million in 2024 to USD 445.40 million by 2032.

Breast Lesion Localization Methods: Introduction

A breast lesion refers to the presence of an abnormal tissue or lump in the breast area. It can be a single or cluster of lumps. Although most lesions are benign (non-cancerous), some might turn out to be malignant (cancerous), hence, early detection is highly imperative. Symptoms for benign breast lesion may include pain in the affected area, fatigue, discomfort or loss of weight and appetite. Whereas changes in breast size, swelling or hardened area inside the underarm or breast are common indicators of malignant breast lesions.

Locating these lesions is extremely crucial in order to get a timely treatment. A breast lesion can be found through a self or clinical exam, which can be later confirmed using an imaging test. Diagnostic methods commonly constitute mammograms, magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasounds.

Breast Lesion Localization Methods Market Analysis

With the rising prevalence of breast cancer, the number of surgeries has been on a rise. When compared to mastectomy, the frequency of breast-conserving (lumpectomy) surgery is higher. This is because it only removes the area of tumour and allows faster recovery as well. Since, these tumours are non-palpable, they require localization, which can be done through an ultrasound or mammography. As a result, the breast lesion localization methods market value has increased over the years.

Over the years, wire guided localization (WGL) has been commonly used for the surgical excision of a non-palpable breast lesion. This can be accredited to its low cost, high efficacy, and ease of accessibility. However, owing to several logistical challenges like its placement, patient discomfort and a possibility of wire dislocation, breast surgeons have showed their preference for other techniques like radioactive seed localization, radio-occult lesion localization (ROLL), and intraoperative ultrasound. As a result, the market for breast lesion localization has been evolving and welcoming new developments.

New localization devices like SAVI SCOUT®, Localizer™, Molli™, Magseed®, EnVisio®, and Pintuition® have flourished the market. MELODY (Methods for Localization of Different types of breast lesions) is another initiative launched by the European Breast Cancer Research Association of Surgical Trialists and the iBRA-NET. It allows the study of breast localization techniques and devices from various perspectives by enrolling a cohort of breast cancer patients, undergoing breast-conserving surgery using imaging-guided localization. Such initiatives indicate that we can observe breast lesion localization methods market growth in the upcoming years.

Breast Lesion Localization Methods Market Segmentation

Market Breakup by Product Type

  • Localization Wires
  • Radioactive Seeds
  • Magnetic Tracers
  • Others

Market Breakup by Technique

  • Wire Localization
  • Radioactive Seed Localization
  • Magnetic Tracers
  • Others

Market Breakup by Application 

  • Diagnostic 
  • Therapeutic

Market Breakup by End User

  • Diagnostic Centers
  • Hospitals
  • Oncology Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region- 7MM

  • United States
  • EU-4 and the United Kingdom
  • Japan

Breast Lesion Localization Methods Market Overview

The occurrence of breast cancer has been more common than lung cancer. Approximately, 297,790  women in the United States alone are estimated to be diagnosed with lung cancer in 2024. As a result, Unites States holds the largest breast lesion localization methods market share. With a high-tech infrastructure and the presence of major universities and healthcare industry pioneers, there has been significant emphasis on bringing quality diagnostics and treatments for the patients. Moreover, WHO recently released a Global Breast Cancer Initiative Framework that provides a roadmap to save around 2.5 million  lives from breast cancer by 2040.

In addition, India partnered with the United States to develop an artificial intelligence (AI)-enabled digital pathology platform that will enable better diagnosis and prediction of therapeutic benefits to the patients. The US-India cancer dialogue also aims to bring the public and private sector that envisions around data sharing and synthetic biology.

Breast Lesion Localization Methods Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Boston Scientific Corporation
  • BD
  • Medtronic
  • Abbott
  • Cook
  • Stryker
  • Wright Medical Group N.V.
  • Zimmer Biomet
  • Smith+Nephew
  • Boston Scientific Corporation
  • Organogenesis Inc.
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Kubtec X-Ray
  • Miltenyi Biotec GMBH
  • Naviscan
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Merit Medical Systems

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technique
  • Application
  • End User
  • Region- 7MM
Breakup by Product Type
  • Localization Wires
  • Radioactive Seeds
  • Magnetic Tracers
  • Others
Breakup by Technique
  • Wire Localization
  • Radioactive Seed Localization
  • Magnetic Tracers
  • Others
Breakup by Application
  • Diagnostic
  • Therapeutic
Breakup by End User
  • Diagnostic Centres
  • Hospitals
  • Oncology Clinics
  • Ambulatory Surgical Centres
  • Others
Breakup by Region- 7MM
  • United States
  • EU-4 and the United Kingdom
  • Japan
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Boston Scientific Corporation
  • BD
  • Medtronic
  • Abbott
  • Cook
  • Stryker
  • Wright Medical Group N.V.
  • Zimmer Biomet
  • Smith+Nephew
  • Boston Scientific Corporation
  • Organogenesis Inc.
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Kubtec X-Ray
  • Miltenyi Biotec GMBH
  • Naviscan
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Merit Medical Systems

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 292.08 million in 2023, driven by the emphasis on preventing deaths associated with breast cancer across the globe.

The market is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032, likely to reach a market value of USD by 445.40 million by 2032.

The prevalence of breast cancer in women has surpassed lung cancer. When going through surgery, the preference for breast-conserving surgery (lumpectomy) is greater than mastectomy. As lumpectomy requires a breast lesion localization technique, the market demand has increased.

The transition from wire guided localization to radio-occult lesion localization (ROLL), radioactive seed localization, and intraoperative ultrasound is the current trend. Moreover, WHO has launched Global Breast Cancer Initiative Framework, focused on decreasing breast cancer mortalities. Similarly, there has been an India-US partnership to focus on AI enabled digital platforms.

Common types of products include localization wires, radioactive seeds, and magnetic tracers, among others.

It finds wide application in diagnostics and therapeutics.

Wire localization, radioactive seed localization, and magnetic tracers, among others are some of the techniques.

The major regions of the market include the United States, Japan, EU-4, and the United Kingdom.

End users in the market include hospitals, diagnostic centers, oncology clinics, and ambulatory surgical centers, among others.

Key players involved in the market are Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Stryker, Wright Medical Group N.V., Zimmer Biomet, Smith+Nephew, Boston Scientific Corporation, Organogenesis Inc., Arthrex, Inc., Orthofix Medical Inc., Kubtec X-Ray, Miltenyi Biotec GMBH, Naviscan, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Merit Medical Systems.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124